TCR beta-chain variable region-driven selection and massive expansion of HLA-class I-restricted antitumor CTL lines from HLA-A*0201+ melanoma patients. [PDF]
C Maccalli+4 more
openalex +1 more source
Interplay of integrins and selectins in metastasis
Here we review the role of integrins and their interplay with selectins in metastasis. The efficacy of integrin‐targeted therapies may be reduced in tumors where metastasis relies heavily on selectins. In certain tumors, integrins and selectins exhibit a synergistic interaction during intraperitoneal dissemination.
Diana Maltseva+2 more
wiley +1 more source
Patient-Selection of a Clinical Trial Primary Outcome: The ENHANCE-AF Outcomes Survey. [PDF]
Stafford RS+10 more
europepmc +1 more source
Likelihood of Contact with AIDS Patients as a Factor in Medical Studentsʼ Residency Selections
ROBERTA NESS+4 more
openalex +1 more source
Morphological classification of abdominal aortic aneurysm in selection of patients for endovascular grafting [PDF]
Matthew P. Armon+3 more
openalex +1 more source
Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson+11 more
wiley +1 more source
Regarding “Selection of patients for cardiac evaluation before peripheral vascular operations” [PDF]
Don Poldermans+2 more
openalex +1 more source
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu+11 more
wiley +1 more source
Novel device therapies in heart failure: focus on patient selection. [PDF]
Balgobind A+5 more
europepmc +1 more source